Related references
Note: Only part of the references are listed.Microbiota-induced obesity requires farnesoid X receptor
Ava Parseus et al.
GUT (2017)
The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease
Kazuya Okushin et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Nonalcoholic Fatty Liver Disease and the Gut Microbiome
Jerome Boursier et al.
CLINICS IN LIVER DISEASE (2016)
Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
R. Pencek et al.
DIABETES OBESITY & METABOLISM (2016)
Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
R. J. Hodge et al.
DIABETES OBESITY & METABOLISM (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet Cells to Promote Glucose Homeostasis
Divya P. Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Matthew J. Armstrong et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules
Bryan L. Copple et al.
PHARMACOLOGICAL RESEARCH (2016)
LIPID BIOLOGY Why high 'good cholesterol' can be bad news
Jennifer Couzin-Frankel
SCIENCE (2016)
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
Claudia D. Fuchs et al.
SEMINARS IN LIVER DISEASE (2016)
Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health
Susan A. Joyce et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 7 (2016)
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists
Valentina Sepe et al.
SCIENTIFIC REPORTS (2016)
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
Evie P. M. Broeders et al.
CELL METABOLISM (2015)
FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Rotonya M. Carr et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
Daniel Jahn et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
Rohit Kohli et al.
DIGESTIVE DISEASES (2015)
Bariatric surgery and nonalcoholic fatty liver disease
Guy Bower et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
Niels van Best et al.
HEPATOLOGY INTERNATIONAL (2015)
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
Michaela Mueller et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander
Ester Vanni et al.
SEMINARS IN LIVER DISEASE (2015)
The Gut Microbiota and Nonalcoholic Fatty Liver Disease
Eamonn M. Quigley et al.
SEMINARS IN LIVER DISEASE (2015)
Pharmacotherapy for Nonalcoholic Fatty Liver Disease
Samer Gawrieh et al.
SEMINARS IN LIVER DISEASE (2015)
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Sanjaya K. Satapathy et al.
SEMINARS IN LIVER DISEASE (2015)
TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
Alessia Perino et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Genetic background in nonalcoholic fatty liver disease: A comprehensive review
Fabio Salvatore Macaluso et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
Lihua Jin et al.
SCIENTIFIC REPORTS (2015)
Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
Jorge C. Correia et al.
MOLECULAR METABOLISM (2015)
The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
Jason M. Ridlon et al.
ACTA PHARMACEUTICA SINICA B (2015)
Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids
Courtney B. Ferrebee et al.
ACTA PHARMACEUTICA SINICA B (2015)
Nuclear bile acid signaling through the farnesoid X receptor
Claire Mazuy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development
Iker Uriarte et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Thematic Review Series: Intestinal Lipid Metabolism: New Developments and Current Insights Intestinal transport and metabolism of bile acids
Paul A. Dawson et al.
JOURNAL OF LIPID RESEARCH (2015)
Bile acid receptors and nonalcoholic fatty liver disease
Liyun Yuan et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction
Xijun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Rifaat Safadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
State of the art: treatment of nonalcoholic steatohepatitis
Michelle Pearlman et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Bile acids and the gut microbiome
Jason M. Ridlon et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Knocking on FXR's Door: The Hammerhead-Structure Series of FXR Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Christian Gege et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
The bile acid TGR5 membrane receptor: From basic research to clinical application
Henri Duboc et al.
DIGESTIVE AND LIVER DISEASE (2014)
Bile acid receptors as targets for drug development
Frank G. Schaap et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Bile acid receptors in non-alcoholic fatty liver disease
Yuanyuan Li et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
Rachel H. McMahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
Bile acid sequestrants: more than simple resins
Carolien Out et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Patented TGR5 modulators: a review (2006-present)
Antimo Gioiello et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
Thuy-Anh Le et al.
HEPATOLOGY (2012)
Selection of the appropriate method for the assessment of insulin resistance
Anwar Borai et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease
Rika Iwata et al.
CLINICAL SCIENCE (2011)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Hepatic Overexpression of Abcb11 Promotes Hypercholesterolemia and Obesity in Mice
Anne S. Henkel et al.
GASTROENTEROLOGY (2011)
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Michael R. Charlton et al.
GASTROENTEROLOGY (2011)
Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
Naiara Beraza et al.
GUT (2011)
Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
Mitsuhiro Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Thijs W. H. Pols et al.
JOURNAL OF HEPATOLOGY (2011)
Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
Bertrand Cariou et al.
NUTRITION & METABOLISM (2011)
Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte
Fan Chao et al.
ATHEROSCLEROSIS (2010)
High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
Ulrich F. H. Leuschner et al.
HEPATOLOGY (2010)
Pathology of nonalcoholic fatty liver disease
Elizabeth M. Brunt
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
Songwen Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level
C. Alarcon et al.
DIABETOLOGIA (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat
A Geier et al.
JOURNAL OF HEPATOLOGY (2005)
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
S Katsuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Regulation of carbohydrate metabolism by the farnesoid X receptor
KR Stayrook et al.
ENDOCRINOLOGY (2005)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis
A Figge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile secretory function in the obese Zucker rat:: evidence of cholestasis and altered canalicular transport function
M Pizarro et al.
GUT (2004)
Identification of membrane-type receptor for bile acids (M-BAR)
T Maruyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA
M Nakahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
